Table 3A: Overall
survival in relation to OC use.
|
n |
HR
crude (95% CI) |
d/m |
HR
adjusteda (95% CI) |
d/m |
HR adjustedb
(95% CI) |
d/m |
Total BC cases |
765 |
764 |
190/1 |
755 |
185/10 |
413 |
107/352 |
OC never |
364 |
1.00 |
115/0 |
1.00 |
114/4 |
1.00 |
69/170 |
OC ever |
400 |
0.58 (0.43-0.77)* |
75/0 |
0.77 (0.56-1.10) |
71/5 |
0.67 (0.43-1.04) |
38/181 |
N(number) stands for total
cases included in the analysis, d for total deaths in analyses and m for
missing data.
aAdjusted
for age, BMI, and socioeconomic status
bAdjusted
for age BMI, socioeconomic status, size of tumor, lymphnod einvolvement, grade of
tumor (according to Nottingham), PgR, ER, HER2, P27, Ki67.